{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:49:06Z","timestamp":1788817746283,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPVVM0101"],"award-info":[{"award-number":["CMRPVVM0101"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPVVN0241"],"award-info":[{"award-number":["CMRPVVN0241"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bj.2024.100744","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T02:21:40Z","timestamp":1715221300000},"page":"100744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The synergy of 177Lu-FAPI-46 with tyrosine kinase inhibitor in a sarcoma patient-derived xenograft mouse model"],"prefix":"10.1016","volume":"47","author":[{"given":"Jing-Ren","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Lung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hua","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kung-Chu","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsiu","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8217-1692","authenticated-orcid":false,"given":"Chun-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bj.2024.100744_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3949\/ccjm.89a.21078","article-title":"Soft tissue sarcoma: Recognizing a rare disease","volume":"89","author":"Ardakani","year":"2022","journal-title":"Cleve Clin J Med"},{"issue":"6","key":"10.1016\/j.bj.2024.100744_bib2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1053\/j.semnuclmed.2021.06.009","article-title":"PET\/CT Variants and Pitfalls in bone and soft tissue sarcoma","volume":"51","author":"Benz","year":"2021","journal-title":"Semin Nucl Med"},{"issue":"1","key":"10.1016\/j.bj.2024.100744_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00259-019-04553-8","article-title":"Good clinical practice recommendations for the use of PET\/CT in oncology","volume":"47","author":"Sala\u00fcn","year":"2020","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"2","key":"10.1016\/j.bj.2024.100744_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/1535-7163.MCT-11-0340","article-title":"Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy","volume":"11","author":"Brennen","year":"2012","journal-title":"Mol Cancer Therapeut"},{"issue":"3","key":"10.1016\/j.bj.2024.100744_bib5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00259-021-05554-2","article-title":"Fibroblast activation protein targeted therapy using [(177)Lu]FAPI-46 compared with [(225)Ac]FAPI-46 in a pancreatic cancer model","volume":"49","author":"Liu","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"11","key":"10.1016\/j.bj.2024.100744_bib6","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1097\/RLU.0000000000003810","article-title":"Feasibility and therapeutic potential of 177Lu-fibroblast activation protein inhibitor-46 for patients with relapsed or refractory cancers: a preliminary study","volume":"46","author":"Assadi","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.bj.2024.100744_bib7","first-page":"16","article-title":"Pazopanib in advanced soft tissue sarcomas. Signal Transduct Targeted","volume":"4","author":"Lee","year":"2019","journal-title":"Ther"},{"issue":"2","key":"10.1016\/j.bj.2024.100744_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/biom11020263","article-title":"(177)Lu-PSMA-617 therapy in mice, with or without the Antioxidant \u03b1(1)-Microglobulin (A1M), including kidney damage assessment using (99m)Tc-MAG3 imaging","volume":"11","author":"Kristiansson","year":"2021","journal-title":"Biomolecules"},{"issue":"23","key":"10.1016\/j.bj.2024.100744_bib9","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.3390\/cancers13235962","article-title":"A patient-derived xenograft model of dedifferentiated endometrial carcinoma: a proof-of-concept study for the identification of new molecularly informed treatment approaches","volume":"13","author":"Lin","year":"2021","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.bj.2024.100744_bib10","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1007\/s00259-022-05785-x","article-title":"SNMMI and IAEA enabling guide: how to set up a theranostics centre","volume":"49","author":"Herrmann","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"2","key":"10.1016\/j.bj.2024.100744_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of (177)Lu-dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.bj.2024.100744_bib12","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.bj.2024.100744_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-022-03405-8","article-title":"Asadzadeh Aghdaei H, Baghaei K.Patient-derived xenograft (PDX) models, applications and challenges in cancer research","volume":"20","author":"Abdolahi","year":"2022","journal-title":"J Transl Med"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417024000477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417024000477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T16:52:33Z","timestamp":1722271953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417024000477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2319417024000477"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2024.100744","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The synergy of 177Lu-FAPI-46 with tyrosine kinase inhibitor in a sarcoma patient-derived xenograft mouse model","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2024.100744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chang Gung University.","name":"copyright","label":"Copyright"}],"article-number":"100744"}}